APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Rabies Vaccine Industry Growth and Trends Forecast to 2032

26 December 2025104 pages

Choose your research edition.

Industry ResearchHuman Rabies Vaccine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Human Rabies Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Rabies Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Rabies Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Rabies Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Rabies Vaccine include Zhuoyi Biological, ZhongKe Biopharm, Henan Grand Biopharma, Ningbo Rongan Biological, Prcmise, KANGH, Chengda Bio, Sanofi-Pasteur and Indian Immunologicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Rabies Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Rabies Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Rabies Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Rabies Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Rabies Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Rabies Vaccine Market by Company

Zhuoyi Biological

ZhongKe Biopharm

Henan Grand Biopharma

Ningbo Rongan Biological

Prcmise

KANGH

Chengda Bio

Sanofi-Pasteur

Indian Immunologicals

Bharat Biotech

Bavarian Nordic

Human Rabies Vaccine Segment by Type

Vero Cell

BHK

Human Diploid Cells

Chick Embryo Cell

Others

Human Rabies Vaccine Segment by Application

Pre-Exposure Vaccine

Post-Exposure Vaccine

Human Rabies Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vero Cell Table 2. Major Company of BHK Table 3. Major Company of Human Diploid Cells Table 4. Major Company of Chick Embryo Cell Table 5. Major Company of Others Table 6. Global Human Rabies Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 8. Global Human Rabies Vaccine Sales Market Share in Volume by Type (2021-2026) Table 9. Global Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 10. Global Human Rabies Vaccine Sales Market Share in Value by Type (2021-2026) Table 11. Global Human Rabies Vaccine Price by Type (2021-2026) & (US$/Unit) Table 12. Global Human Rabies Vaccine Sales by Type (2027-2032) & (K Units) Table 13. Global Human Rabies Vaccine Sales Market Share in Volume by Type (2027-2032) Table 14. Global Human Rabies Vaccine Sales by Type (2027-2032) & (US$ Million) Table 15. Global Human Rabies Vaccine Sales Market Share in Value by Type (2027-2032) Table 16. Global Human Rabies Vaccine Price by Type (2027-2032) & (US$/Unit) Table 17. North America Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 18. North America Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Europe Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Latin America Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Human Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Human Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 27. Human Rabies Vaccine Industry Trends Table 28. Human Rabies Vaccine Industry Drivers Table 29. Human Rabies Vaccine Industry Opportunities and Challenges Table 30. Human Rabies Vaccine Industry Restraints Table 31. Global Human Rabies Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Human Rabies Vaccine Revenue Market Share by Company (2021-2026) Table 33. Global Human Rabies Vaccine Sales by Company (2021-2026) & (K Units) Table 34. Global Human Rabies Vaccine Sales Share by Company (2021-2026) Table 35. Global Human Rabies Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Human Rabies Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Human Rabies Vaccine Major Company Production Sites and Headquarters Table 38. Global Human Rabies Vaccine Company, Product Type & Application Table 39. Global Human Rabies Vaccine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Human Rabies Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Human Rabies Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Human Rabies Vaccine Sales Market Share in Volume by Region (2021-2026) Table 45. Global Human Rabies Vaccine Sales by Region (2021-2026) & (US$ Million) Table 46. Global Human Rabies Vaccine Sales Market Share in Value by Region (2021-2026) Table 47. Global Human Rabies Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Human Rabies Vaccine Sales by Region (2027-2032) & (K Units) Table 49. Global Human Rabies Vaccine Sales Market Share in Volume by Region (2027-2032) Table 50. Global Human Rabies Vaccine Sales by Region (2027-2032) & (US$ Million) Table 51. Global Human Rabies Vaccine Sales Market Share in Value by Region (2027-2032) Table 52. Global Human Rabies Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Human Rabies Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 55. Global Human Rabies Vaccine Sales Market Share in Volume by Application (2021-2026) Table 56. Global Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 57. Global Human Rabies Vaccine Sales Market Share in Value by Application (2021-2026) Table 58. Global Human Rabies Vaccine Price by Application (2021-2026) & (US$/Unit) Table 59. Global Human Rabies Vaccine Sales by Application (2027-2032) & (K Units) Table 60. Global Human Rabies Vaccine Sales Market Share in Volume by Application (2027-2032) Table 61. Global Human Rabies Vaccine Sales by Application (2027-2032) & (US$ Million) Table 62. Global Human Rabies Vaccine Sales Market Share in Value by Application (2027-2032) Table 63. Global Human Rabies Vaccine Price by Application (2027-2032) & (US$/Unit) Table 64. North America Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 65. North America Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Europe Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Latin America Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Human Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Human Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 74. Zhuoyi Biological Company Information Table 75. Zhuoyi Biological Business Overview Table 76. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhuoyi Biological Human Rabies Vaccine Product Portfolio Table 78. Zhuoyi Biological Recent Development Table 79. ZhongKe Biopharm Company Information Table 80. ZhongKe Biopharm Business Overview Table 81. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. ZhongKe Biopharm Human Rabies Vaccine Product Portfolio Table 83. ZhongKe Biopharm Recent Development Table 84. Henan Grand Biopharma Company Information Table 85. Henan Grand Biopharma Business Overview Table 86. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Henan Grand Biopharma Human Rabies Vaccine Product Portfolio Table 88. Henan Grand Biopharma Recent Development Table 89. Ningbo Rongan Biological Company Information Table 90. Ningbo Rongan Biological Business Overview Table 91. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio Table 93. Ningbo Rongan Biological Recent Development Table 94. Prcmise Company Information Table 95. Prcmise Business Overview Table 96. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Prcmise Human Rabies Vaccine Product Portfolio Table 98. Prcmise Recent Development Table 99. KANGH Company Information Table 100. KANGH Business Overview Table 101. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. KANGH Human Rabies Vaccine Product Portfolio Table 103. KANGH Recent Development Table 104. Chengda Bio Company Information Table 105. Chengda Bio Business Overview Table 106. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Chengda Bio Human Rabies Vaccine Product Portfolio Table 108. Chengda Bio Recent Development Table 109. Sanofi-Pasteur Company Information Table 110. Sanofi-Pasteur Business Overview Table 111. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sanofi-Pasteur Human Rabies Vaccine Product Portfolio Table 113. Sanofi-Pasteur Recent Development Table 114. Indian Immunologicals Company Information Table 115. Indian Immunologicals Business Overview Table 116. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Indian Immunologicals Human Rabies Vaccine Product Portfolio Table 118. Indian Immunologicals Recent Development Table 119. Bharat Biotech Company Information Table 120. Bharat Biotech Business Overview Table 121. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Bharat Biotech Human Rabies Vaccine Product Portfolio Table 123. Bharat Biotech Recent Development Table 124. Bavarian Nordic Company Information Table 125. Bavarian Nordic Business Overview Table 126. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Bavarian Nordic Human Rabies Vaccine Product Portfolio Table 128. Bavarian Nordic Recent Development Table 129. North America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. North America Human Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 131. North America Human Rabies Vaccine Sales Market Share by Country (2021-2026) Table 132. North America Human Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 133. North America Human Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 134. North America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Human Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Human Rabies Vaccine Market Share by Country (2021-2026) Table 137. North America Human Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Human Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 139. Europe Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Europe Human Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 141. Europe Human Rabies Vaccine Sales Market Share by Country (2021-2026) Table 142. Europe Human Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 143. Europe Human Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Human Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Human Rabies Vaccine Market Share by Country (2021-2026) Table 147. Europe Human Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Human Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Human Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 151. Asia-Pacific Human Rabies Vaccine Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Human Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 153. Asia-Pacific Human Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Human Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Human Rabies Vaccine Market Share by Country (2021-2026) Table 157. Asia-Pacific Human Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Human Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 159. Latin America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Latin America Human Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 161. Latin America Human Rabies Vaccine Sales Market Share by Country (2021-2026) Table 162. Latin America Human Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 163. Latin America Human Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Human Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Human Rabies Vaccine Market Share by Country (2021-2026) Table 167. Latin America Human Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Human Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Human Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 171. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Human Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 173. Middle East and Africa Human Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Human Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Human Rabies Vaccine Market Share by Country (2021-2026) Table 177. Middle East and Africa Human Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Human Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Human Rabies Vaccine Distributors List Table 182. Human Rabies Vaccine Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Human Rabies Vaccine Image Figure 2. Global Human Rabies Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rabies Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Rabies Vaccine Sales (2021-2032) & (K Units) Figure 5. Vero Cell Image Figure 6. Global Vero Cell Sales YoY Growth (2021-2032) & (K Units) Figure 7. BHK Image Figure 8. Global BHK Sales YoY Growth (2021-2032) & (K Units) Figure 9. Human Diploid Cells Image Figure 10. Global Human Diploid Cells Sales YoY Growth (2021-2032) & (K Units) Figure 11. Chick Embryo Cell Image Figure 12. Global Chick Embryo Cell Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Human Rabies Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Human Rabies Vaccine Market Share by Type 2025 VS 2032 Figure 17. North America Human Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. North America Human Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Europe Human Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Europe Human Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Latin America Human Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Human Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Human Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Human Rabies Vaccine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Pre-Exposure Vaccine Image Figure 30. Global Pre-Exposure Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 31. Post-Exposure Vaccine Image Figure 32. Global Post-Exposure Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Human Rabies Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Rabies Vaccine Market Share by Application 2025 VS 2032 Figure 35. North America Human Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 45. North America Human Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Human Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Human Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Human Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Human Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Human Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Rabies Vaccine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Rabies Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vero Cell
  • BHK
  • Human Diploid Cells
  • Chick Embryo Cell
  • Others
Applications
  • Pre-Exposure Vaccine
  • Post-Exposure Vaccine
Companies covered
  • Zhuoyi Biological
  • ZhongKe Biopharm
  • Henan Grand Biopharma
  • Ningbo Rongan Biological
  • Prcmise
  • KANGH
  • Chengda Bio
  • Sanofi-Pasteur
  • Indian Immunologicals
  • Bharat Biotech
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Rabies Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Rabies Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Rabies Vaccine Market by Type
  6. 1.3.1 Vero Cell
  7. 1.3.2 BHK
  8. 1.3.3 Human Diploid Cells
  9. 1.3.4 Chick Embryo Cell
  10. 1.3.5 Others
  11. 1.4 Global Human Rabies Vaccine Market Size by Type
  12. 1.4.1 Global Human Rabies Vaccine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Human Rabies Vaccine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Human Rabies Vaccine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Human Rabies Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Human Rabies Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Human Rabies Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Human Rabies Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Human Rabies Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Rabies Vaccine Industry Trends
  2. 2.2 Human Rabies Vaccine Industry Drivers
  3. 2.3 Human Rabies Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Rabies Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Rabies Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Rabies Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Human Rabies Vaccine Price (2021-2026)
  4. 3.4 Global Human Rabies Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Rabies Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Human Rabies Vaccine Company, Product Type & Application
  7. 3.7 Global Human Rabies Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Rabies Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Rabies Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Rabies Vaccine Tier 1, Tier 2, and Tier 3
4 Human Rabies Vaccine Regional Status and Outlook
  1. 4.1 Global Human Rabies Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Rabies Vaccine Historic Market Size by Region
  3. 4.2.1 Global Human Rabies Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Rabies Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Rabies Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Human Rabies Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Rabies Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Rabies Vaccine by Application
  1. 5.1 Human Rabies Vaccine Market by Application
  2. 5.1.1 Pre-Exposure Vaccine
  3. 5.1.2 Post-Exposure Vaccine
  4. 5.2 Global Human Rabies Vaccine Market Size by Application
  5. 5.2.1 Global Human Rabies Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Rabies Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Rabies Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Rabies Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Rabies Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Rabies Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Rabies Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Rabies Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhuoyi Biological
  2. 6.1.1 Zhuoyi Biological Company Information
  3. 6.1.2 Zhuoyi Biological Business Overview
  4. 6.1.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhuoyi Biological Human Rabies Vaccine Product Portfolio
  6. 6.1.5 Zhuoyi Biological Recent Developments
  7. 6.2 ZhongKe Biopharm
  8. 6.2.1 ZhongKe Biopharm Company Information
  9. 6.2.2 ZhongKe Biopharm Business Overview
  10. 6.2.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
  12. 6.2.5 ZhongKe Biopharm Recent Developments
  13. 6.3 Henan Grand Biopharma
  14. 6.3.1 Henan Grand Biopharma Company Information
  15. 6.3.2 Henan Grand Biopharma Business Overview
  16. 6.3.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
  18. 6.3.5 Henan Grand Biopharma Recent Developments
  19. 6.4 Ningbo Rongan Biological
  20. 6.4.1 Ningbo Rongan Biological Company Information
  21. 6.4.2 Ningbo Rongan Biological Business Overview
  22. 6.4.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
  24. 6.4.5 Ningbo Rongan Biological Recent Developments
  25. 6.5 Prcmise
  26. 6.5.1 Prcmise Company Information
  27. 6.5.2 Prcmise Business Overview
  28. 6.5.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Prcmise Human Rabies Vaccine Product Portfolio
  30. 6.5.5 Prcmise Recent Developments
  31. 6.6 KANGH
  32. 6.6.1 KANGH Company Information
  33. 6.6.2 KANGH Business Overview
  34. 6.6.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 KANGH Human Rabies Vaccine Product Portfolio
  36. 6.6.5 KANGH Recent Developments
  37. 6.7 Chengda Bio
  38. 6.7.1 Chengda Bio Company Information
  39. 6.7.2 Chengda Bio Business Overview
  40. 6.7.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chengda Bio Human Rabies Vaccine Product Portfolio
  42. 6.7.5 Chengda Bio Recent Developments
  43. 6.8 Sanofi-Pasteur
  44. 6.8.1 Sanofi-Pasteur Company Information
  45. 6.8.2 Sanofi-Pasteur Business Overview
  46. 6.8.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
  48. 6.8.5 Sanofi-Pasteur Recent Developments
  49. 6.9 Indian Immunologicals
  50. 6.9.1 Indian Immunologicals Company Information
  51. 6.9.2 Indian Immunologicals Business Overview
  52. 6.9.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Indian Immunologicals Human Rabies Vaccine Product Portfolio
  54. 6.9.5 Indian Immunologicals Recent Developments
  55. 6.10 Bharat Biotech
  56. 6.10.1 Bharat Biotech Company Information
  57. 6.10.2 Bharat Biotech Business Overview
  58. 6.10.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bharat Biotech Human Rabies Vaccine Product Portfolio
  60. 6.10.5 Bharat Biotech Recent Developments
  61. 6.11 Bavarian Nordic
  62. 6.11.1 Bavarian Nordic Company Information
  63. 6.11.2 Bavarian Nordic Business Overview
  64. 6.11.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bavarian Nordic Human Rabies Vaccine Product Portfolio
  66. 6.11.5 Bavarian Nordic Recent Developments
7 North America by Country
  1. 7.1 North America Human Rabies Vaccine Sales by Country
  2. 7.1.1 North America Human Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Rabies Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Human Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Rabies Vaccine Market Size by Country
  6. 7.2.1 North America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Rabies Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Rabies Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Rabies Vaccine Sales by Country
  2. 8.1.1 Europe Human Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Rabies Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Rabies Vaccine Market Size by Country
  6. 8.2.1 Europe Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Rabies Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Rabies Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Rabies Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Human Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Rabies Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Rabies Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Rabies Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Rabies Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Rabies Vaccine Sales by Country
  2. 10.1.1 South America Human Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Rabies Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Human Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Rabies Vaccine Market Size by Country
  6. 10.2.1 South America Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Rabies Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Rabies Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Rabies Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Human Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Rabies Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Rabies Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Human Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Rabies Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Rabies Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Rabies Vaccine Value Chain Analysis
  2. 12.1.1 Human Rabies Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Rabies Vaccine Production Mode & Process
  7. 12.2 Human Rabies Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Rabies Vaccine Distributors
  10. 12.2.3 Human Rabies Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst